CY1123956T1 - Φαρμακευτικη συνθεση, περιλαμβανουσα σωματιδια φωσφορικου συνδετικου - Google Patents

Φαρμακευτικη συνθεση, περιλαμβανουσα σωματιδια φωσφορικου συνδετικου

Info

Publication number
CY1123956T1
CY1123956T1 CY20201100828T CY201100828T CY1123956T1 CY 1123956 T1 CY1123956 T1 CY 1123956T1 CY 20201100828 T CY20201100828 T CY 20201100828T CY 201100828 T CY201100828 T CY 201100828T CY 1123956 T1 CY1123956 T1 CY 1123956T1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical composition
binder particles
phosphate binder
composition including
including phosphate
Prior art date
Application number
CY20201100828T
Other languages
English (en)
Inventor
Laurent CHOFFLON
Erik Philipp
Original Assignee
Vifor (International) Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51987152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1123956(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vifor (International) Ag filed Critical Vifor (International) Ag
Publication of CY1123956T1 publication Critical patent/CY1123956T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σε φαρμακευτική σύνθεση, περιλαμβάνουσα ορισμένα σωματίδια φωσφορικού συνδετικού που έχουν ορισμένη κατανομή μεγέθους σωματιδίου, μέθοδο για τη βιομηχανική κατασκευή της φαρμακευτικής σύνθεσης και τη χρήση σακχαροσιδηρικού οξυυδροξειδίου που έχει ορισμένη κατανομή μεγέθους σωματιδίου για τη βιομηχανική κατασκευή μιας φαρμακευτικής σύνθεσης.
CY20201100828T 2013-11-27 2020-09-03 Φαρμακευτικη συνθεση, περιλαμβανουσα σωματιδια φωσφορικου συνδετικου CY1123956T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP13194632 2013-11-27
EP14156793 2014-02-26
EP14803118.0A EP3073997B1 (en) 2013-11-27 2014-11-26 Pharmaceutical composition, comprising phosphate binder particles
PCT/EP2014/075640 WO2015078900A1 (en) 2013-11-27 2014-11-26 Pharmaceutical composition, comprising phosphate binder particles

Publications (1)

Publication Number Publication Date
CY1123956T1 true CY1123956T1 (el) 2022-03-24

Family

ID=51987152

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20201100828T CY1123956T1 (el) 2013-11-27 2020-09-03 Φαρμακευτικη συνθεση, περιλαμβανουσα σωματιδια φωσφορικου συνδετικου

Country Status (18)

Country Link
US (6) US10624855B2 (el)
EP (3) EP3735962B1 (el)
JP (4) JP6431540B2 (el)
CN (1) CN105764492B (el)
AU (3) AU2014356500B2 (el)
CA (1) CA2931173C (el)
CY (1) CY1123956T1 (el)
DK (1) DK3073997T3 (el)
ES (1) ES2820737T3 (el)
HR (1) HRP20201386T1 (el)
HU (1) HUE051111T2 (el)
LT (1) LT3073997T (el)
MX (1) MX2016006916A (el)
PL (1) PL3073997T3 (el)
PT (1) PT3073997T (el)
RS (1) RS60894B1 (el)
SI (1) SI3073997T1 (el)
WO (1) WO2015078900A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI592159B (zh) 2007-11-16 2017-07-21 威佛（國際）股份有限公司 藥學組成物
WO2020032227A1 (ja) * 2018-08-10 2020-02-13 キッセイ薬品工業株式会社 スクロオキシ水酸化鉄含有顆粒及び医薬組成物
CN109331036A (zh) * 2018-10-17 2019-02-15 上海医药集团青岛国风药业股份有限公司 多糖铁在制备治疗高磷血症的药物中的应用
CN109223824A (zh) * 2018-11-23 2019-01-18 海南高升医药科技开发股份有限公司 一种治疗慢性肾病透析患者高磷血症的药物制备方法
CN112972407A (zh) * 2019-12-18 2021-06-18 南京恒生制药有限公司 一种碳酸司维拉姆片剂组合物及其制备方法
US20220370494A1 (en) * 2020-01-16 2022-11-24 Vifor Fresenius Medical Care Renal Pharma Ltd Particles of a mixture of iron(iii)-oxyhydroxide, sucrose and one or more starches, preferably of sucroferric oxyhydroxide
EP3932535A1 (en) * 2020-07-01 2022-01-05 Vifor Fresenius Medical Care Renal Pharma, Ltd. Manufacturing method for polynuclear iron compounds stabilized by carbohydrates and/or humic acid

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1249558A (en) 1969-08-19 1971-10-13 American Cyanamid Co Process for the preparation of size-controlled colloidal iron sols and their stabilized solutions
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
DE19547356A1 (de) 1995-12-19 1997-06-26 Vifor Int Ag Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung
US6117451A (en) 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
WO2001089484A2 (en) * 2000-05-22 2001-11-29 Verion, Inc. Method for increasing the compressibility of poorly binding powder materials
US6358526B1 (en) 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
DE102004031181A1 (de) * 2004-06-28 2006-01-19 Vifor (International) Ag Phosphatadsorbens
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
US20080014541A1 (en) 2006-05-08 2008-01-17 Bob Sonntag Fluidizing nozzle for high capacity particulate loaders
KR100734922B1 (ko) 2006-11-22 2007-07-03 (주)스마트코퍼레이션 접합용 전자유도가열기
EP1932807A1 (en) * 2006-12-14 2008-06-18 Novartis AG Inorganic compounds
SI2319804T1 (sl) * 2006-12-14 2015-01-30 Novartis Ag Fosfatni adsorbent na osnovi Ĺľelezo(III)-ogljikovega hidrata
DE102007031984A1 (de) 2007-07-10 2009-01-15 Forschungszentrum Karlsruhe Gmbh Reaktor zur hochspannungsimpulstechnischen Desinfektion bakterienverseuchter Flüssigkeiten und Verfahren dazu
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
TWI592159B (zh) * 2007-11-16 2017-07-21 威佛（國際）股份有限公司 藥學組成物
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
GB0913525D0 (en) * 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method

Also Published As

Publication number Publication date
WO2015078900A1 (en) 2015-06-04
AU2020217386B2 (en) 2022-03-24
US20220110874A1 (en) 2022-04-14
JP2018154635A (ja) 2018-10-04
EP3073997B1 (en) 2020-06-03
JP2021138708A (ja) 2021-09-16
HUE051111T2 (hu) 2021-01-28
CN105764492B (zh) 2019-09-13
AU2022204380A1 (en) 2022-07-14
US11446252B2 (en) 2022-09-20
EP3741360A1 (en) 2020-11-25
MX2016006916A (es) 2016-08-17
US10624855B2 (en) 2020-04-21
US20200222328A1 (en) 2020-07-16
EP3735962A1 (en) 2020-11-11
PT3073997T (pt) 2020-09-08
US20200222327A1 (en) 2020-07-16
CA2931173C (en) 2018-10-09
SI3073997T1 (sl) 2021-02-26
CA2931173A1 (en) 2015-06-04
AU2014356500A1 (en) 2016-05-05
EP3735962B1 (en) 2024-03-27
JP6431540B2 (ja) 2018-11-28
US11446251B2 (en) 2022-09-20
ES2820737T3 (es) 2021-04-22
US20220387327A1 (en) 2022-12-08
JP6884124B2 (ja) 2021-06-09
JP2016538299A (ja) 2016-12-08
EP3073997A1 (en) 2016-10-05
AU2014356500B2 (en) 2020-05-21
JP2023175692A (ja) 2023-12-12
US11234937B2 (en) 2022-02-01
JP7335291B2 (ja) 2023-08-29
CN105764492A (zh) 2016-07-13
HRP20201386T1 (hr) 2020-12-25
US20220110875A1 (en) 2022-04-14
LT3073997T (lt) 2020-12-10
DK3073997T3 (da) 2020-09-07
US11234938B2 (en) 2022-02-01
PL3073997T3 (pl) 2021-04-06
RS60894B1 (sr) 2020-11-30
US20170143634A1 (en) 2017-05-25
AU2020217386A1 (en) 2020-09-03

Similar Documents

Publication Publication Date Title
CY1123956T1 (el) Φαρμακευτικη συνθεση, περιλαμβανουσα σωματιδια φωσφορικου συνδετικου
CY1124740T1 (el) Συνθεσεις που περιλαμβανουν συνθετiκα πολυνουκλεοτιδια που κωδικοποιουν crispr σχετικες πρωτεϊνες και συνθετικα sgrnas και μεθοδοι χρησης
EA201400754A3 (ru) Новые фосфатные соединения, способ их получения и фармацевтические композиции, содержащие их
CY1121736T1 (el) Άλατα aramchol
PH12015502293A1 (en) Bispecific antibodies specific for fap and dr5, antibodies specific for dr5 and methods of use
EA201591137A1 (ru) Ингибиторы mk2 и их применения
BR112015032718A2 (pt) composto de modificação de splicing do gene foxm1, uso do composto, formulação farmacêutica e métodos de triagem de compostos
MX357202B (es) Composicion de particula tipo virus.
BR112014028751A2 (pt) partícula encapsulada, e, método para formar uma partícula encapsulada.
MA39883A (fr) Particules inorganiques individualisées
BR112015011139A2 (pt) partícula encapsulada, e, método para formar uma partícula encapsulada.
EP3007778A4 (en) Particle filter mask
EP3043904A4 (en) Manufacture of magnetic particles
MX2015009719A (es) Inhibidores benzoquinolona de vmat2.
EP3071667A4 (en) Luminescent particle, materials and products including same, and methods
SG10201405683YA (en) Emission Source And Method Of Forming The Same
TR201903516T4 (tr) Eri̇yi̇k malzemeni̇n granülasyonu
CY1123408T1 (el) Φαρμακευτικες συνθεσεις και χρηση των αυτων
EA201600412A1 (ru) Способ производства неорганического материала в виде частиц
DOP2014000235A (es) Métodos para producir clorhidrato de anamorelina que tiene contenido controlado de cloruro
MX2016008350A (es) Sistema de dos componentes, en particular para formacion de adhesivo.
PL2835413T3 (pl) Cząstki węglopodobnego ciała stałego, ich zastosowania i sposób wytwarzania
CY1118277T1 (el) Σταθερη φαρμακοτεχνικη μορφη πεξιγανανης
MX2015015899A (es) Metodos para producir particulas que comprenden proteinas terapeuticas.
BR112018016634A2 (pt) partículas de glicina